Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxane HD vs Densiron in Complicated Retinal Detachment
NCT00403702Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Aug 2006
- Primary completion
- Aug 2006
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Oxane HD, Densiron in rhegmatogenous retinal detachment (RRD), sponsored by Asociación para Evitar la Ceguera en México. Planned start Aug 2006; status: withdrawn.
02
Drugs
Oxane HDDensiron
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on NCT00403702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403702.